Duality Advisers’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-15,937
Closed -$300K 375
2024
Q1
$300K Buy
+15,937
New +$273K 0.03% 523
2023
Q4
Sell
-146,779
Closed -$2.55M 700
2023
Q3
$2.55M Buy
146,779
+53,521
+57% +$1.12M 0.31% 103
2023
Q2
$1.94M Buy
+93,258
New +$2.03M 0.24% 161

Other funds holding OGN

Duality Advisers's OGN Position: Q2 2024 in Review

Duality Advisers sold out of Organon & Co (OGN) in Q2 2024, closing a stake of 15,937 shares — an estimated $300K sold.

Duality Advisers first reported a position in OGN in Q2 2023 and held it in 3 quarters. The position peaked at $2.55M in Q3 2023. 724 funds tracked by Wall St. Rank hold OGN as of Q2 2024.

  • Duality Advisers reported no remaining Organon & Co position as of Q2 2024 after selling out during the quarter.
  • Duality Advisers sold 15,937 Organon & Co shares in Q2 2024, an estimated $300K.
  • Duality Advisers first reported a position in Organon & Co in Q2 2023 and held it in 3 quarters.
  • Duality Advisers's Organon & Co position peaked at $2.55M in Q3 2023.
  • 724 funds tracked by Wall St. Rank held Organon & Co as of Q2 2024.

Based on Duality Advisers's 13F filing for Q2 2024.